| Code | 4510E | ||||||||||
| MA number | 44/0163/18-S | ||||||||||
| Product Form: | sol inj 1x7 mg/2,8 ml (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Subcutaneous and intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 22.05.2018 |
| SPC: |
SPC _Bortezomib STADA_10.2023.pdf
|
| PIL: |
PIL_Bortezomib STADA_10.2023.pdf
|
| Safety feature | Yes |
| Data update: | 25.10.2023 |
